MCF-7 ESR1 drug response bulk RNA
RNA-seq (gene expression) · human · 64 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 64 samples: 64 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE255765_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1076488 and SRA study SRP489708. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 64 sample titles: 64 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8079112 LIB5440331_SAM24399127
- GSM8079113 LIB5440332_SAM24399128
- GSM8079114 LIB5440333_SAM24399129
- GSM8079115 LIB5440334_SAM24399130
- GSM8079116 LIB5440335_SAM24399131
- GSM8079117 LIB5440336_SAM24399132
- GSM8079118 LIB5440337_SAM24399133
- GSM8079119 LIB5440338_SAM24399134
- GSM8079120 LIB5440339_SAM24399135
- GSM8079121 LIB5440340_SAM24399136
- GSM8079122 LIB5440341_SAM24399137
- GSM8079123 LIB5440342_SAM24399138
- GSM8079124 LIB5440343_SAM24399139
- GSM8079125 LIB5440344_SAM24399140
- GSM8079126 LIB5440345_SAM24399141
- GSM8079127 LIB5440346_SAM24399142
- GSM8079128 LIB5440347_SAM24399143
- GSM8079129 LIB5440348_SAM24399144
- GSM8079130 LIB5440349_SAM24399145
- GSM8079131 LIB5440350_SAM24399146
- GSM8079132 LIB5440351_SAM24399147
- GSM8079133 LIB5440352_SAM24399148
- GSM8079134 LIB5440353_SAM24399149
- GSM8079135 LIB5440354_SAM24399150
- GSM8079136 LIB5440355_SAM24399151
- GSM8079137 LIB5440356_SAM24399152
- GSM8079138 LIB5440357_SAM24399153
- GSM8079139 LIB5440358_SAM24399154
- GSM8079140 LIB5440359_SAM24399155
- GSM8079141 LIB5440360_SAM24399156
- GSM8079142 LIB5440361_SAM24399157
- GSM8079143 LIB5440362_SAM24399158
- GSM8079144 LIB5440363_SAM24399159
- GSM8079145 LIB5440364_SAM24399160
- GSM8079146 LIB5440365_SAM24399161
- GSM8079147 LIB5440366_SAM24399162
- GSM8079148 LIB5440367_SAM24399163
- GSM8079149 LIB5440368_SAM24399164
- GSM8079150 LIB5440369_SAM24399165
- GSM8079151 LIB5440370_SAM24399166
+ 24 more — browse all 64 samples with per-sample file links →
- GSE325486 ESR1 mutations shape the clonal dynamics, genetic diversity and cellular states of acquired resistance to CDK4/6 inhibitors 57 samples shares esr1
- GSE266407 ESR1 fusions invoke breast cancer subtype-dependent enrichment of ligand independent oncogenic signatures and phenotypes [ChIP-seq] 14 samples shares esr1
- GSE325674 Leveraging experimental evolution to extract predictive collateral drug response signatures in Ewings Sarcoma 73 samples shares drug
- GSE328930 The DUTRENEO trial: bulk prospective biomarker-guided therapy selection and spatial transcriptomic dissection of immunotherapy response in muscle-invasive bladder cancer 66 samples shares bulk
- GSE294532 Multi-layer stratified oncology platform utilizing transcriptomics, prostate cancer organoids, and modeling of drug response 63 samples shares drug
- GSE293952 Hypoxia shapes both therapeutic response and resistance in metastatic clear cell renal cell carcinoma [bulk RNA-seq] 61 samples shares bulk
- GSE205154 Bulk RNA-Seq gene expression data for 289 primary and metastatic pancreatic ductal adenocarcinoma (PDAC) tumor samples from FFPE blocks. 289 samples shares bulk
- GSE281471 Targeting CD206+ macrophages disrupts the establishment of a key anti-tumor immune axis [Bulk RNA-seq] 243 samples shares bulk
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.